Telsey Advisory Group reissued their outperform rating on shares of Waldencast (NASDAQ:WALD - Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $6.00 target price on the stock.
A number of other analysts also recently issued reports on WALD. TD Cowen initiated coverage on Waldencast in a research note on Monday, December 16th. They issued a "hold" rating and a $4.30 target price for the company. DA Davidson raised their target price on Waldencast from $7.25 to $7.50 and gave the stock a "buy" rating in a research note on Wednesday, December 4th. Finally, Canaccord Genuity Group raised their target price on Waldencast from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Waldencast currently has an average rating of "Moderate Buy" and an average price target of $5.76.
Read Our Latest Research Report on WALD
Waldencast Price Performance
NASDAQ WALD traded down $0.02 during trading hours on Wednesday, reaching $3.11. The stock had a trading volume of 105,497 shares, compared to its average volume of 128,289. The stock has a fifty day moving average of $3.24 and a 200 day moving average of $3.47. Waldencast has a 52-week low of $2.41 and a 52-week high of $7.54. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78.
Institutional Trading of Waldencast
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN increased its position in shares of Waldencast by 29.9% during the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock worth $59,000 after purchasing an additional 3,358 shares during the last quarter. Barclays PLC increased its position in shares of Waldencast by 15.1% during the 4th quarter. Barclays PLC now owns 37,342 shares of the company's stock worth $150,000 after purchasing an additional 4,906 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Waldencast by 293.9% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company's stock worth $25,000 after purchasing an additional 5,114 shares during the last quarter. Northern Trust Corp increased its position in shares of Waldencast by 4.1% during the 4th quarter. Northern Trust Corp now owns 167,662 shares of the company's stock worth $674,000 after purchasing an additional 6,640 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Waldencast by 10.3% during the 4th quarter. Renaissance Technologies LLC now owns 91,800 shares of the company's stock worth $369,000 after purchasing an additional 8,600 shares during the last quarter. 41.97% of the stock is owned by institutional investors and hedge funds.
About Waldencast
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading

Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.